How Accenture is using Google Cloud and Wiz to close security blind spots in modern multi-cloud infrastructure
United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 4 minute read Pharma Industry News VERAXA Biotech seals $1.64bn SPAC merger to launch Nasdaq oncology powerhouse Find out how VERAXA Biotech’s $1.64B Nasdaq listing is set to redefine cancer treatment with next-gen antibody therapies. byPallavi MadhirajuApril 25, 2025